KR920000323A - 재흡수성이 향상된 소마토스타틴 약학적 조성물, 그것의 제법 및 용도 - Google Patents

재흡수성이 향상된 소마토스타틴 약학적 조성물, 그것의 제법 및 용도 Download PDF

Info

Publication number
KR920000323A
KR920000323A KR1019910010018A KR910010018A KR920000323A KR 920000323 A KR920000323 A KR 920000323A KR 1019910010018 A KR1019910010018 A KR 1019910010018A KR 910010018 A KR910010018 A KR 910010018A KR 920000323 A KR920000323 A KR 920000323A
Authority
KR
South Korea
Prior art keywords
somatostatin
composition
formula
acid
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019910010018A
Other languages
English (en)
Korean (ko)
Inventor
프리케 제르
본데르쉐 재키
Original Assignee
장 크라머 한스 루돌프 하우스
산도즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 장 크라머 한스 루돌프 하우스, 산도즈 리미티드 filed Critical 장 크라머 한스 루돌프 하우스
Publication of KR920000323A publication Critical patent/KR920000323A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019910010018A 1990-06-15 1991-06-14 재흡수성이 향상된 소마토스타틴 약학적 조성물, 그것의 제법 및 용도 Withdrawn KR920000323A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9013448.7 1990-06-15
GB909013448A GB9013448D0 (en) 1990-06-15 1990-06-15 Pharmaceutical resorption-improved somatostatin compositions,their preparation and use

Publications (1)

Publication Number Publication Date
KR920000323A true KR920000323A (ko) 1992-01-29

Family

ID=10677720

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910010018A Withdrawn KR920000323A (ko) 1990-06-15 1991-06-14 재흡수성이 향상된 소마토스타틴 약학적 조성물, 그것의 제법 및 용도

Country Status (21)

Country Link
EP (1) EP0462071B1 (enExample)
JP (1) JPH04230223A (enExample)
KR (1) KR920000323A (enExample)
AU (1) AU7833191A (enExample)
CA (1) CA2044511A1 (enExample)
CH (1) CH683069A5 (enExample)
DE (1) DE4119062A1 (enExample)
ES (1) ES2067906T3 (enExample)
FI (1) FI912868A7 (enExample)
FR (1) FR2663227B1 (enExample)
GB (2) GB9013448D0 (enExample)
HU (1) HUT59007A (enExample)
IE (1) IE912010A1 (enExample)
IL (1) IL98477A0 (enExample)
IT (1) IT1297205B1 (enExample)
LU (1) LU87952A1 (enExample)
NO (1) NO912271L (enExample)
NZ (1) NZ238522A (enExample)
PT (1) PT97964A (enExample)
TW (1) TW226332B (enExample)
ZA (1) ZA914583B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9203769D0 (en) * 1992-02-21 1992-04-08 Sandoz Ltd Improvements in or relating to organic compounds
CA2145302C (en) * 1993-07-30 2008-10-28 Masahiko Dohi Peptide proteinaceous drug nasal powder composition
GB9417524D0 (en) * 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
MXPA02010316A (es) * 2000-04-19 2005-04-19 Borody Thomas J Terapia novedosa para los trastornos asociados con la hiperlipidemia.
US20030083241A1 (en) * 2001-11-01 2003-05-01 Young Charles W. Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation
WO2007057457A2 (en) 2005-11-21 2007-05-24 Novartis Ag Neuroendocrine tumor treatment using mtor inhibitors
US8318657B2 (en) * 2005-12-01 2012-11-27 Flinders Technologies Pty Ltd. Methods and compositions for preventing and/or treating pancreatitis
WO2010032140A2 (en) 2008-09-17 2010-03-25 Chiasma Inc. Pharmaceutical compositions and related methods of delivery
GB0817969D0 (en) * 2008-10-01 2008-11-05 Axcess Ltd Pharmaceutical composition
FI3253401T3 (fi) 2015-02-03 2025-07-09 Amryt Endo Inc Akromegallian hoitaminen suun kautta annettavalla oktreotidilla
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
HU198626B (en) * 1986-05-27 1989-11-28 Sandoz Ag Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient
JPS632932A (ja) * 1986-06-23 1988-01-07 Teijin Ltd 経鼻投与用粉末状組成物
HU203204B (en) * 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid

Also Published As

Publication number Publication date
ZA914583B (en) 1993-02-24
GB9112509D0 (en) 1991-07-31
GB2244918B (en) 1994-06-15
IE912010A1 (en) 1991-12-18
ITRM910430A1 (it) 1992-12-17
ES2067906T3 (es) 1995-04-01
LU87952A1 (fr) 1993-01-15
EP0462071A1 (en) 1991-12-18
IT1297205B1 (it) 1999-08-03
FI912868A0 (fi) 1991-06-13
HU911849D0 (en) 1991-12-30
DE4119062A1 (de) 1991-12-19
FR2663227B1 (fr) 1995-04-28
FI912868L (fi) 1991-12-16
FI912868A7 (fi) 1991-12-16
CA2044511A1 (en) 1991-12-16
PT97964A (pt) 1992-03-31
HUT59007A (en) 1992-04-28
AU7833191A (en) 1992-01-02
TW226332B (enExample) 1994-07-11
GB2244918A (en) 1991-12-18
NO912271L (no) 1991-12-16
GB9013448D0 (en) 1990-08-08
IL98477A0 (en) 1992-07-15
NZ238522A (en) 1993-10-26
ITRM910430A0 (it) 1991-06-17
NO912271D0 (no) 1991-06-13
EP0462071B1 (en) 1995-02-01
CH683069A5 (de) 1994-01-14
JPH04230223A (ja) 1992-08-19
FR2663227A1 (fr) 1991-12-20

Similar Documents

Publication Publication Date Title
CA2467222A1 (en) Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
DE60209907T2 (de) Verwendung von oestrogenverbindungen zur steigerung der libido bei frauen
KR920000323A (ko) 재흡수성이 향상된 소마토스타틴 약학적 조성물, 그것의 제법 및 용도
GB2091556A (en) Aqueous preparation of 1a 25-dihydroxycholecalciferol
BR9908488A (pt) Composição farmacêutica de topiramato
RU98115774A (ru) Новые производные 19-нор-прегнена
PT94038B (pt) Processo para a preparacao de composicoes farmaceuticas que contem di-hidroespirorenona como antiandrogenio
KR940002210A (ko) 24-시클로프로판 비타민 d 유도체
SI1257280T1 (sl) Farmacevtska kombinacija mikroniziranega drospirenona za hormonsko nadomestno terapijo
CA2448278A1 (en) Drug delivery system comprising a tetrahidroxilated estrogen for use in hormonal contraception
CA2467237A1 (en) Method of preventing or treating benign gynaecological disorders
CN1694710A (zh) 15－或16－位取代的睾酮类似物的药物学应用
Selye On the toxicity of oestrogens with special reference to diethylstilboestrol
KR970061249A (ko) 골다공증을 치료 또는 방지하기 위한 조성물
US4252797A (en) Corticosteroid calcium compositions and treatment of rheumatic diseases therewith
KR940005275A (ko) 1α,24(R)-디히드록시-22(E)-데히드로-비타민D₃로 이루어지는 골다공증 치료용 제약 조성물
KR890004705A (ko) 항바이러스성 제제
KR940005276A (ko) 1α, 25-디히드록시-22(E)-데히드로-비타민 D₃로 이루어지는 골다공증 치료용 제약 조성물
KR900701278A (ko) 바이러스 감염 치료용 담즙산
Hall Clinical experiences with the sublingual administration of alpha estradiol
KR830009776A (ko) 세포 보호 유도방법
Schwedes et al. Prevention of chemically induced adrenal hemorrhage and lung injury by somatostatin in the rat
US3129137A (en) Method of inhibiting gastro-intestinal irritation
RU1789216C (ru) Состав, обладающий контрацептивным действием
AU729898B2 (en) Transdermal therapeutic system having an active compound combination comprising oestriol

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19910614

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid